From rational design to serendipity : discovery of novel thiosemicarbazones as potent trypanocidal compounds.

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorBraga, Saulo Fehelberg Pinto-
Autor(es): dc.creatorSantos, Viviane Corrêa-
Autor(es): dc.creatorVieira, Rafael Pinto-
Autor(es): dc.creatorSilva, Elany Barbosa da-
Autor(es): dc.creatorMonti, Ludovica-
Autor(es): dc.creatorKrake, Susann Hannelore-
Autor(es): dc.creatorMartinez, Pablo D. G.-
Autor(es): dc.creatorDias, Luiz Carlos-
Autor(es): dc.creatorCaffrey, Conor R.-
Autor(es): dc.creatorSiqueira Neto, Jair Lage de-
Autor(es): dc.creatorOliveira, Renata Barbosa de-
Autor(es): dc.creatorFerreira, Rafaela Salgado-
Data de aceite: dc.date.accessioned2025-08-21T15:12:12Z-
Data de disponibilização: dc.date.available2025-08-21T15:12:12Z-
Data de envio: dc.date.issued2023-10-16-
Data de envio: dc.date.issued2023-10-16-
Data de envio: dc.date.issued2021-
Fonte completa do material: dc.identifierhttp://www.repositorio.ufop.br/jspui/handle/123456789/17593-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S0223523422007784-
Fonte completa do material: dc.identifierhttps://doi.org/10.1016/j.ejmech.2022.114876-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1005644-
Descrição: dc.descriptionChagas disease is a major public health problem caused by Trypanosoma cruzi, with an estimated 6–7 million people infected and 70 million at risk of infection. T. brucei gambiense and T. brucei rhodesiense are two subspecies of related parasites that cause human African trypanosomiasis, a neglected tropical disease with also millions of people at risk of infection. Pharmacotherapy for both diseases suffers from low efficacy, side effects, or drug resistance. Recently, we reported a noncovalent competitive inhibitor of cruzain (IC50 26 μM, Ki 3 μM) and TbrCatL (IC50 50 μM), two cysteine proteases considered promising drug targets for trypanosomiasis. Here, we describe the design and synthesis of derivatives of our lead compound. The new thiosemicarbazone derivatives showed potency in the nanomolar concentration range against the two enzymes, but they were later charac- terized as aggregators. Nevertheless, the thiosemicarbazone derivatives showed promising antiparasitic activities against T. b. brucei (EC50 13–49.7 μM) and T. cruzi (EC50 0.027–0.59 μM) under in vitro conditions. The most active thiosemicarbazone was 200-fold more potent than the current anti-chagasic drug, benznidazole, and showed a selectivity index of 370 versus myoblast cells. We have identified an excellent candidate for further optimization and in vivo studies.-
Formato: dc.formatapplication/pdf-
Idioma: dc.languageen-
Direitos: dc.rightsrestrito-
Palavras-chave: dc.subjectCruzain-
Palavras-chave: dc.subjectTbrCatL - rhodesain-
Palavras-chave: dc.subjectTrypanosoma cruzi-
Palavras-chave: dc.subjectTrypanosoma brucei-
Título: dc.titleFrom rational design to serendipity : discovery of novel thiosemicarbazones as potent trypanocidal compounds.-
Aparece nas coleções:Repositório Institucional - UFOP

Não existem arquivos associados a este item.